EMPAGLIFLOZIN
Clinical Indication
Chronic heart failure with reduced ejection fraction.
Comments
In line with NICE TA773
Date of classification
May 2022
Yellow
Medicines initiated or recommended by a specialist service for prescribing in primary care which do not require initiation or ongoing oversight by the specialist. There are no specific paperwork requirements between provider organisations and a verbal request may be acceptable through advice and guidance as long enough information is provided so that the transfer of care is safe.